WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR November 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

CLINICAL STUDY OF DICKKOPF-3 SERUM IN MOSUL PATIENTS' CHRONIC RENAL

Hiba R. Kamal* and Thikra A. Allwsh

ABSTRACT

Introduction: Dickkopf-3 (DKK-3) participates in cell signaling pathways, inflammation, and tissue remodeling, secreted within the renal tubular membrane in response to stress and a gradual reduction in kidney function typifies chronic kidney disease. The study aimed to evaluate the Dickkopf-3 level in serum of Mosul Patients' Chronic Renal and the effect of many factors on its. Methods: The study established specific criteria for the participation of 150 participants, encompassing individuals of both sexes aged 30 to 70 years. The participants were categorized into 2 groups: 75 healthy individuals and 75 patients with CKD. Tests were conducted to assess the levels of renal function, DKK-3 in the serum, and qPCR for the DKK-3 gene. Results indicated chronic kidney patients demonstrated a significant increase in Age, blood pressure (BP), and BMI, in addition to renal function: GFR, creatinine, urea Cystatin-C, uric acid, Albumin, and total protein compared to a control group. An inverse relationship exists between BMI and age with DKK–3 serum and an increase in DKK–3 in smokers in control and patient groups. There was a significant increase in levels of DKK-3 in patients' group serum compared to the control group at (p ≤ 0.001) depending on BMI, age, sex, and smoking. The study's results also showed an increase in the level of DKK3 in patients, which is considered one of the main reasons for the development of the pathological condition. Conclusion: The study suggests that DKK-3 correlates with decreased kidney function and clinical symptoms. The high DKK3 in the serum of patients may indicate the onset and progression of kidney disease. As a result, DKK-3 may be a potential target for treatment.

[Full Text Article] [Download Certificate]